BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 19195605)

  • 21. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.
    Ypenburg C; Sieders A; Bleeker GB; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2007 Dec; 154(6):1160-5. PubMed ID: 18035090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy.
    Cabrera-Bueno F; García-Pinilla JM; Peña-Hernández J; Jiménez-Navarro M; Gómez-Doblas JJ; Barrera-Cordero A; Alzueta-Rodríguez J; de Teresa-Galván E
    Europace; 2007 Sep; 9(9):757-61. PubMed ID: 17573358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?
    Yu CM; Zhang Q; Yip GW; Chan YS; Lee PW; Wu LW; Lam YY; Kum LC; Chan HC; Chan S; Fung JW
    Am J Cardiol; 2006 Oct; 98(8):1083-7. PubMed ID: 17027576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of opposite left ventricular basal and apical rotation predicts acute response to cardiac resynchronization therapy and is associated with long-term reversed remodeling.
    Rüssel IK; Götte MJ; de Roest GJ; Marcus JT; Tecelão SR; Allaart CP; de Cock CC; Heethaar RM; van Rossum AC
    J Card Fail; 2009 Oct; 15(8):717-25. PubMed ID: 19786261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
    Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
    J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.
    Yu CM; Bleeker GB; Fung JW; Schalij MJ; Zhang Q; van der Wall EE; Chan YS; Kong SL; Bax JJ
    Circulation; 2005 Sep; 112(11):1580-6. PubMed ID: 16144994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure.
    Molhoek SG; Bax JJ; Bleeker GB; Holman ER; Van Erven L; Bootsma M; Boersma E; Steendijk P; Van Der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):701-7. PubMed ID: 16050826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy.
    Liang YJ; Zhang Q; Fung JW; Chan JY; Yip GW; Lam YY; Yu CM
    Eur Heart J; 2010 Oct; 31(19):2359-68. PubMed ID: 20501482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
    Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
    Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy.
    Ypenburg C; Lancellotti P; Tops LF; Boersma E; Bleeker GB; Holman ER; Thomas JD; Schalij MJ; Piérard LA; Bax JJ
    Eur Heart J; 2008 Mar; 29(6):757-65. PubMed ID: 18305084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy.
    Di Biase L; Auricchio A; Sorgente A; Civello K; Klersy C; Faletra F; Riedlbauchova L; Patel D; Arruda M; Schweikert RA; Martin DO; Saliba WI; Moccetti T; Wilkoff BL; Natale A
    Eur Heart J; 2008 Oct; 29(20):2497-505. PubMed ID: 18515806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops.
    Steendijk P; Tulner SA; Bax JJ; Oemrawsingh PV; Bleeker GB; van Erven L; Putter H; Verwey HF; van der Wall EE; Schalij MJ
    Circulation; 2006 Mar; 113(10):1295-304. PubMed ID: 16520415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    Sénéchal M; Lancellotti P; Magne J; Garceau P; Champagne J; Philippon F; O'Hara G; Moonen M; Dubois M
    Am J Cardiol; 2010 Jul; 106(1):31-7. PubMed ID: 20609643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
    Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of 'super-responders' to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry.
    António N; Teixeira R; Coelho L; Lourenço C; Monteiro P; Ventura M; Cristóvão J; Elvas L; Gonçalves L; Providência LA
    Europace; 2009 Mar; 11(3):343-9. PubMed ID: 19240109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience.
    Cha YM; Rea RF; Wang M; Shen WK; Asirvatham SJ; Friedman PA; Munger TM; Espinosa RE; Hodge DO; Hayes DL; Redfield MM
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1015-9. PubMed ID: 17711439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization.
    Markowitz SM; Lewen JM; Wiggenhorn CJ; Abraham WT; Stein KM; Iwai S; Lerman BB
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):293-8. PubMed ID: 19175852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling.
    Lilli A; Ricciardi G; Porciani MC; Perini AP; Pieragnoli P; Musilli N; Colella A; Del Pace S; Michelucci A; Turreni F; Sassara M; Achilli A; Barold SS; Padeletti L
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1349-55. PubMed ID: 17976098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization.
    Becker M; Hoffmann R; Schmitz F; Hundemer A; Kühl H; Schauerte P; Kelm M; Franke A
    Am J Cardiol; 2007 Dec; 100(11):1671-6. PubMed ID: 18036367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.